What does PHARMAZINNES do?

PHARMAZINNES is a pharmacy in Namur. Private Limited, started on 20 September 2019, 1 establishment.

What is the address of PHARMAZINNES?

The registered office of PHARMAZINNES is located at Rue Patenier 15, 5000 Namur.

Is PHARMAZINNES still active?

Yes. According to the CBE (2 October 2026) PHARMAZINNES is active, legal situation “Normale toestand”, started on 20 September 2019.

Is PHARMAZINNES registered on Peppol?

Yes, PHARMAZINNES is registered on the Peppol network with ID 0208:0734679978.

What is the enterprise number of PHARMAZINNES?

The enterprise number of PHARMAZINNES is BE0734679978.

When was PHARMAZINNES founded?

PHARMAZINNES was founded on 20 September 2019.

Who are the directors of PHARMAZINNES?

According to the 2025 annual accounts, the directors of PHARMAZINNES are: MADELEINE LELIEVRE DE STAUMONT PAULINE.

Is PHARMAZINNES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 September 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMAZINNES make in 2025?

PHARMAZINNES posted a profit after taxes of € 50,293 in financial year 2025.

What is the revenue of PHARMAZINNES?

As a small company, PHARMAZINNES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 231,990.

How much does an employee at PHARMAZINNES earn?

The average wage cost per full-time employee at PHARMAZINNES was € 57,900 in 2025: staff costs of € 86,834 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMAZINNES have?

According to the 2025 annual accounts, PHARMAZINNES has 1.5 full-time equivalents (FTE).

PHARMAZINNES (Private Limited) - Namur - BE0734679978

Dossier PHARMAZINNES, printed on 2 October 2026 from databakkes.be/en/0734679978/pharmazinnes. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMAZINNES from Namur, company number BE0734679978, closed financial year 2025 with a result of € 50,293 after tax. For that financial year PHARMAZINNES recorded a gross margin of € 231,990 and equity of € 121,685. Compared with financial year 2024, the result moved from € 27,140 to € 50,293. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 121,685

▲ 68% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 50,293

▲ 85% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 166,984

▲ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

2 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

1.5

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 86,834

▲ 17% vs 2024

€ 57,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 12,846

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 473,822

▼ 14% vs 2024

€ 78,398 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 69,616

▲ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 16,686

▲ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 181,795 Gross margin 2022: € 181,795 First fiscal year in the series	€ 181,967 Gross margin 2023: € 181,967 Unchanged (€ 181,795) Favourable step	€ 207,447 Gross margin 2024: € 207,447 ▲ 14% vs 2023 (€ 181,967) Favourable step	€ 231,990 Gross margin 2025: € 231,990 ▲ 12% vs 2024 (€ 207,447) Favourable step	▲ 12%
Profit after taxes	€ 27,306 Profit after taxes 2022: € 27,306 First fiscal year in the series	€ 16,155 Profit after taxes 2023: € 16,155 ▼ 41% vs 2022 (€ 27,306) Unfavourable step	€ 27,140 Profit after taxes 2024: € 27,140 ▲ 68% vs 2023 (€ 16,155) Favourable step	€ 50,293 Profit after taxes 2025: € 50,293 ▲ 85% vs 2024 (€ 27,140) Favourable step	▲ 85%
Equity	€ 73,763 Equity 2022: € 73,763 First fiscal year in the series	€ 45,918 Equity 2023: € 45,918 ▼ 38% vs 2022 (€ 73,763) Unfavourable step	€ 72,225 Equity 2024: € 72,225 ▲ 57% vs 2023 (€ 45,918) Favourable step	€ 121,685 Equity 2025: € 121,685 ▲ 68% vs 2024 (€ 72,225) Favourable step	▲ 68%
Total debts	€ 821,167 Total debts 2022: € 821,167 First fiscal year in the series	€ 947,544 Total debts 2023: € 947,544 ▲ 15% vs 2022 (€ 821,167) Unfavourable step	€ 823,312 Total debts 2024: € 823,312 ▼ 13% vs 2023 (€ 947,544) Favourable step	€ 753,540 Total debts 2025: € 753,540 ▼ 8% vs 2024 (€ 823,312) Favourable step	▼ 8%
Cash	€ 92,629 Cash 2022: € 92,629 First fiscal year in the series	€ 64,837 Cash 2023: € 64,837 ▼ 30% vs 2022 (€ 92,629) Unfavourable step	€ 108,885 Cash 2024: € 108,885 ▲ 68% vs 2023 (€ 64,837) Favourable step	€ 166,984 Cash 2025: € 166,984 ▲ 53% vs 2024 (€ 108,885) Favourable step	▲ 53%
Land & buildings	€ 276,804 Land & buildings 2022: € 276,804 First fiscal year in the series	€ 263,134 Land & buildings 2023: € 263,134 ▼ 5% vs 2022 (€ 276,804) Unchanged	€ 252,622 Land & buildings 2024: € 252,622 ▼ 4% vs 2023 (€ 263,134) Unchanged	€ 241,618 Land & buildings 2025: € 241,618 ▼ 4% vs 2024 (€ 252,622) Unchanged	▼ 4%
Retained profit	€ 28,763 Retained profit 2022: € 28,763 First fiscal year in the series	€ 918 Retained profit 2023: € 918 ▼ 97% vs 2022 (€ 28,763) Unfavourable step	€ 27,225 Retained profit 2024: € 27,225 ▲ € 26,307 vs 2023 (€ 918) Favourable step	€ 76,685 Retained profit 2025: € 76,685 ▲ 182% vs 2024 (€ 27,225) Favourable step	▲ 182%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 44,000 Dividend 2023: € 44,000 ▲ € 43,200 vs 2022 (€ 800) Unchanged	€ 833 Dividend 2024: € 833 ▼ 98% vs 2023 (€ 44,000) Unchanged	€ 833 Dividend 2025: € 833 Unchanged (€ 833) Unchanged
Bank debt	€ 706,426 Bank debt 2022: € 706,426 First fiscal year in the series	€ 629,315 Bank debt 2023: € 629,315 ▼ 11% vs 2022 (€ 706,426) Favourable step	€ 551,788 Bank debt 2024: € 551,788 ▼ 12% vs 2023 (€ 629,315) Favourable step	€ 473,822 Bank debt 2025: € 473,822 ▼ 14% vs 2024 (€ 551,788) Favourable step	▼ 14%
Balance sheet total	€ 894,930 Balance sheet total 2022: € 894,930 First fiscal year in the series	€ 993,462 Balance sheet total 2023: € 993,462 ▲ 11% vs 2022 (€ 894,930) Unchanged	€ 895,537 Balance sheet total 2024: € 895,537 ▼ 10% vs 2023 (€ 993,462) Unchanged	€ 875,224 Balance sheet total 2025: € 875,224 ▼ 2% vs 2024 (€ 895,537) Unchanged	▼ 2%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	-	1.3 Employees (FTE) 2024: 1.3 First fiscal year in the series	1.5 Employees (FTE) 2025: 1.5 ▲ 0.2 vs 2024 (1.3) Unchanged	▲ 0.2

Key figures of PHARMAZINNES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMAZINNES?

What happened at PHARMAZINNES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 50,293 (▲ 85% vs 2024). Source: NBB ↗
Sep 20, 2019 New establishment in Namur. KBO
2019 MADELEINE LELIEVRE DE STAUMONT PAULINE became a director. NBB
Sep 20, 2019 Start of the company according to the CBE. KBO

In short

From € 27,306 profit in 2022 to € 50,293 profit in 2025.

Paid € 26,758 in corporate taxes since 2022.

Best year ever: 2025, with € 50,293 profit.

On average € 154,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMAZINNES? We notify you, reason included.

Follow PHARMAZINNES

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MADELEINE LELIEVRE DE STAUMONT PAULINE

PHARMAZINNES

Behind PHARMAZINNES is MADELEINE LELIEVRE DE STAUMONT PAULINE.

See the full network in the app

Directors

According to the 2025 annual accounts

MADELEINE LELIEVRE DE STAUMONT PAULINE

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Patenier 15

5000 Namur

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0734.679.978
VAT number: BE 0734.679.978
Registered office: Rue Patenier 15, 5000 Namur
Names & denominations: PHARMAZINNES
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 September 2019
Peppol: Active · Active since 12 Dec 2025
Contact: [email protected]
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗